Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
May 8th, 2009
Acute lymphoblastic leukemia (ALL) is a complex heterogeneous disease which, despite significant advances in the treatment of pediatric patients, is often fatal in adults. It is critical for healthcare professionals who treat adult patients with ALL to maintain an up-to-date understanding of the multitude of factors affecting management options for this challenging disease. To address the need for current education on treatment challenges and emerging therapies in ALL, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education online activity and podcast titled Expert Insights...
Source: Health Business Week (2009-05-08)
|
